TrialAnnals of surgical oncology2017

Short-Course Radiotherapy Followed by Neoadjuvant Bevacizumab, Capecitabine, and Oxaliplatin and Subsequent Radical Treatment in Primary Stage IV Rectal Cancer: Long-Term Results of a Phase II Study.

C Bisschop et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.